For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
As the use of oxaliplatin in the treatment of gastrointestinal, gynecologic, and other cancers continues to grow, so too does the incidence of hypersensitivity reactions connected to the drug. Because the development of HSRs may require patients to discontinue oxaliplatin even if it’s effective against their cancer, oncology nurses need to be able to prevent or minimize reactions whenever possible.
- Read more about For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
- Add new comment
$88 Billion for Health Care; Raising the Tobacco Age; 2020 Healthcare Push
According to a Gallup Poll released on April 2, 2019, Americans borrowed approximately $88 billion to pay for health care in 2018. At a National Academies of Science healthcare conference on April 4, the main takeaway was that many Americans surveyed reported that they could not afford to have a serious illness like cancer. The cost of care, even with insurance, is more than many can financially withstand. Oncology nurses know how patients must maneuver through the system to defer costs, sometimes resulting in delayed or alternative approaches to care.
- Read more about $88 Billion for Health Care; Raising the Tobacco Age; 2020 Healthcare Push
- Add new comment
ONCC Welcomes New Executive Director
The Oncology Nursing Certification Corporation (ONCC)—an independent affiliate of the Oncology Nursing Society (ONS)—has been providing oncology nurses with certification to demonstrate their expertise and excellence in oncology nursing care for more than 30 years. On April 8, 2019, ONCC will welcome Tony Ellis, CAE, as its new executive director. Following the retirement of long-time director Cynthia Miller Murphy, MSN, RN, CAE, FAAN, Ellis will be only the second person in ONCC history to serve executive director.
Miller Murphy Retires After Storied Career in Oncology
As a vanguard for oncology nursing certification and practice excellence, Cynthia Miller Murphy, MSN, RN, CAE, FAAN, executive director for the Oncology Nursing Certification Corporation (ONCC), is a nationally recognized expert in credentialing. Her tenure as ONCC executive director helped nurses achieve more than 100,000 different certifications to demonstrate their commitment to excellence in nursing and patient-centered care. After almost 30 years at ONCC, Miller Murphy is retiring as executive director effective April 8, 2019.
ONS Hosts Inaugural International Oncology Nursing Conference in Azerbaijan
Although cancer isn’t one of the very highest causes of death in Azerbaijan, the nation still feels the impact of the global cancer burden: lung cancer and gastrointestinal cancers rank number 8 and 10, respectively, on the top 10 causes of death in the country, and their incidence is growing. As part of its commitment to sustainable international programs to support the advancement of cancer care, ONS and its members have a responsibility to disseminate knowledge to international nurses in countries like Azerbaijan.
- Read more about ONS Hosts Inaugural International Oncology Nursing Conference in Azerbaijan
- Add new comment
Health Policy Begins With You: Educate Your Representatives in Cancer Care
As an oncology advanced practice nurse and administrator for cancer services, every day I care for patients and caregivers coping with cancer. I mentor nursing staff in best practices to deliver care, and I create a work environment conducive to advancing quality cancer care. However, my commitment to supporting people with cancer does not end at the walls of my workplace. Oncology nurses are called to be a visible change agent in our communities—and beyond—to continue the worthy work of championing quality care for people diagnosed with cancer, along with spreading prevention and early detection information.
- Read more about Health Policy Begins With You: Educate Your Representatives in Cancer Care
- Add new comment
FDA Oncology Center of Excellence Establishes a Commitment to Patients
The U.S. Food and Drug Administration’s (FDA’s) mission is primarily to protect the American public by regulating the sale and development of consumer items like cosmetics, food, tobacco products, medication, and much more. However, a lesser known arm is FDA’s Oncology Center of Excellence, established to further prevention, detection, patient-centered research, and cancer-specific education.
- Read more about FDA Oncology Center of Excellence Establishes a Commitment to Patients
- Add new comment
Drug Pricing Discussions Make Headway in Congress
The 116th congressional session is well underway. Committee meetings are being held and policy discussions are taking shape all over Capitol Hill. In January 2019, the U.S. House and Senate held separate public hearings on the biggest healthcare issue from the 2018 midterm election: drug pricing.
Obesity-Related Cancer Incidence Increases in Young Adults
A new study showed that incidence rates are increasing for 6 of the 12 obesity-related cancers in U.S. young adults and that, over time, the increases are occurring in progressively younger ages and successively younger generations. The findings were published in Lancet Public Health.
Geriatric Assessments Can Improve Shared Decision Making, Patient Satisfaction
As people age, their risk for cancer increases, and so too does the complexity of their cancer care. Older patients with cancer typically present with age-related conditions like comorbidities, functional problems, falling, and polypharmacy, which are not as widely discussed in the oncology space as they should be. Age-
related concerns can influence outcomes for patients with cancer and their caregivers, including treatment toxicity, hospitalization, and even early mortality.